Study of the Research Medicine CIN-103 in Adults With Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D).

Clinical trial NCT06153420 · TERMINATED

Trial details

NCT number: NCT06153420
Sponsor: CinPhloro Pharma, LLC
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Irritable Bowel Syndrome With Diarrhea

Start date: 2023-12-28
Primary completion: 2025-07-28
Enrollment: 421

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.